FMO5 and diabetic cardiomyopathy: Although evidence exists for increased production of ROS from NADPH oxidase or reduced neuronal nitric oxide synthase (NOS1) activity coupled with increased activation of XO [12], [13], the role of and possible involvement of other enzymes such as XO, and 5-LO in diabetic cardiomyopathy remain unclear.